Breaking News, Promotions & Moves

Inovio Names Chief Commercial Officer

Steven Egge will lead the company's commercial strategy and operations as it prepares to potentially launch its first DNA medicine product.

Author Image

By: Charlie Sternberg

Associate Editor

INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, has appointed Steven Egge as Chief Commercial Officer. Egge will lead the company’s commercial strategy and operations as it prepares to potentially launch its first DNA medicine product, INO-3107 as a treatment for recurrent respiratory papillomatosis (RRP). “We are delighted to welcome Steve to I...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters